Innovative oncology leaders increasingly recognize the value of upstream investments in early detection programs, such as cancer screening and incidental findings programs, to catch potential cancers early and ensure patients return to their facilities for the follow-up care they need.

‍

In this webinar, LCMC Health, RWJBarnabas Health, and Virtua Health discuss why they launched these programs and the positive impact of these investments on stage shift and downstream revenue. Panelists review:

‍

• Financial pro forma: A line-by-line breakdown of how a 300-bed hospital managing incidental lung nodules could potentially generate over $15 million in additional revenue from cancer treatments.
• Client outcomes: Success stories including 80-90%+ patient return rates, a 20%+ reduction in late-stage diagnoses, and a significant increase in downstream volume fueled by the expansion of their programs
• Making the pitch: Best practices for making the internal business case and operationalizing the program at scale.

‍